Section Editors

Section Board for 'Hepatitis Virus Vaccines' (6)

Please see the section webpage for more information on this section.

Dr. Yee-Joo Tan
Section Editor-in-Chief
Infectious Diseases Translational Research Programme and Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Singapore, Singapore
Interests: Characterization of newly emerged viruses and hepatitis viruses; Development of antibodies for diagnostic and therapeutic applications; Protein engineering
Dr. Brian Conway
Vancouver Infectious Diseases Centre, Vancouver, BC V6Z 2C7, Canada
Interests: HIV infection; HCV infection; inner city medicine
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. C.A.H.H. (Toos) Daemen
Department of Medical Microbiology, University of Groningen, 9700 RB Groningen, The Netherlands
Interests: cancer immunotherapy; therapeutic vaccines; HPV; Hepatitis C virus; intratumoral immune environment; alphavirus-based vaccines
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. Wolfram H. Gerlich
The Institute for Medical Virology, Justus Liebig University, 35392 Giessen, Germany (Retired)
Interests: hepatitis B virus; viral hepatitis; hepadnaviruses; vaccines; antiviral therapy; viral diagnosis; immune assays
Dr. Carlo Saitta
Unit of Clinical and Molecular Hepatology, Department of Internal Medicine, University Hospital of Messina, Messina, Italy
Interests: hepatocellular carcinoma; viral hepatitis; HBV; HCV; non-alcoholic steatohepatitis; liver steatosis; cholangiocarcinoma; primary biliary cholangitis; liver cirrhosis; portal hypertension.
Dr. Ryosuke Suzuki

Department of Virology II, National Institute of Infectious Diseases, Tokyo 162-0052, Japan
Interests: hepatitis viruses; flaviviruses; reverse genetics; vaccine; neutralizing antibody
Back to TopTop